ASPA and amyotrophic lateral sclerosis: After validating that serum NAA levels were increased in ALS mice (Fig. 4H), as previously described in humans, we demonstrated that this condition was coupled with a decreased content of the metabolite in the spinal cord (Fig. 4I) and no change in ASPA levels (Supplementary Fig. 5E, F).